# Antibody internalization and intracellular trafficking

Source: https://onco.cc/terms/antibody-internalization-trafficking/  
OnCo record `antibody-internalization-trafficking` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

After binding a cell, an antibody drug may be taken inside, recycled or processed. These movements affect how much active drug reaches the place where it acts.

## Summary

A quantitative study of a trastuzumab-maytansinoid conjugate separated surface binding, internalization, degradation, payload movement and intracellular binding. It found that processing rates influenced delivered payload in the studied cell lines. Surface staining or uptake alone does not establish release of an active species at its intracellular target. The relevant processing steps depend on the construct and its linker-payload chemistry.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: ADC internalization; antibody uptake and recycling; endosomal ADC trafficking

## Sources

- Cellular processing rates and conjugate design (2016): https://doi.org/10.1208/s12248-016-9892-3

## Connected records

- terms: [Antigen expression and treatment response](https://onco.cc/terms/antigen-expression-and-response/), [Drug target engagement](https://onco.cc/terms/drug-target-engagement/), [Evidence from measurement to patient benefit](https://onco.cc/terms/measurement-to-benefit-evidence/), [Linker (ADC)](https://onco.cc/terms/linker/), [Lysosomal payload transport](https://onco.cc/terms/lysosomal-payload-egress/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)

---
JSON: https://onco.cc/api/v1/entities/antibody-internalization-trafficking.json